Recently, multiple lines of evidence suggested that the expression of pleiotrophin (PTN), which is a secreted growth factor that binds to receptor protein tyrosine phosphatase zeta (PTPRZ1) to stimulate human endothelial cell migration, is associated with poor prognosis in a variety of malignant tumours [6]. This evidence concerns the gene PTPRZ1 and cancer.